Previous 10 | Next 10 |
ADES, AGM, AIV, AKBA, ALCO, ALTO, AMC, AMPH, AMWL, ANGI, APPF, APTO, ARCT, AROC, ASLE, ASRT, ATER, AVIR, AZTA, BATL, BHF, BLFS, BLI, BLNK, BODY, OTCPK:BOWFF, BRMK, BRT, BW, BWXT, CAPL, CARA, CARG, CHMI, CLAR, CLOV, CNNE, CSTL, OTCPK:CURLF, DDD, DHT, DNB, ENTA, EQH, EVBG, FCRD, FF, FGEN, FLL, ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips These cheap stocks offer incredible long-term value for under $10. Assertio Holdings ( ASRT ): New-look business post-restructuring which is poised for healthy top and bottom-line expansion this year Nokia (...
LAKE FOREST, Ill., April 22, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it will release first quarter 2022 financial results on Monday, May 9, 2022, after the close of markets. Followin...
Company grows the top-line by 7% in Q4 due to strong performances from Indocin, Cambia & Zipsor. Promising guidance eventually led to a breakout above the January highs. We look at Assertio's profitability and valuation metrics to see if the breakout has merit. For furth...
Although small-cap stocks can be more volatile than large-cap stocks, cheap stocks under $10 have high return potential. Over the last 52-weeks, Small-cap stocks (IWM -7.1%) have significantly underperformed Large-cap stocks (IWB +11.7%). Our Quant-based picks under $10 are strong...
LAKE FOREST, Ill., March 31, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio”) (NASDAQ: ASRT) and BlinkRx, the leading patient access solution, today announced a collaboration to support healthcare professionals and their patients undergoing treatment with Otrexup....
Assertio Holdings, Inc. (ASRT) Q4 2021 Earnings Conference Call March 09, 2022, 09:00 AM ET Company Participants Max Nemmers - Head-Investor Relations and Administration Daniel Peisert - President and Chief Executive Officer Paul Schwichtenberg - Senior Vice President and Chief Financial Offi...
Assertio Therapeutics press release (NASDAQ:ASRT): Q4 GAAP EPS of $0.10 misses by $0.02. Revenue of $33.33M (+10.5% Y/Y) beats by $2.56M. Non-GAAP adjusted EBITDA for the fourth quarter of $17.8 million represents growth of 13% versus the third quarter and 118% versus the prior year. Sh...
The following slide deck was published by Assertio Holdings, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Assertio Holdings, Inc. 2021 Q4 - Results - Earnings Call Presentation
$32.2 Million Fourth Quarter Net Product Sales, a 7% Increase from Fourth Quarter 2020 and $109.4 Million Full Year Net Product Sales $17.8 Million Fourth Quarter Non-GAAP Adjusted EBITDA, a 118% Increase from Fourth Quarter 2020 and $48.8 Million Full Year N...
News, Short Squeeze, Breakout and More Instantly...
Assertio Therapeutics Inc. Company Name:
ASRT Stock Symbol:
NASDAQ Market:
Assertio Therapeutics Inc. Website:
LAKE FOREST, Ill., July 24, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that it will rel...
2024-07-03 07:15:03 ET H.C. Wainwright analyst issues BUY recommendation for ASRT on July 3, 2024 06:04AM ET. ASRT was trading at $1.15 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recommendati...
LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Ajay Patel, Chief...